Compendium of Cancer Genome Aberrations

Volunteer Assignments and Opportunities: Difference between revisions

← Older editNewer edit →
VisualWikitext
No edit summary
Snehal.Patel (talk | contribs)
editor
270 edits
No edit summary
(86 intermediate revisions by 6 users not shown)
Line 14: Line 14:
|
|
|
|
|PENDING
|complete
|
|
|Fabiola Quintero-Rivera (FQR)
|Fabiola Quintero-Rivera (FQR)
Line 24: Line 24:
|
|
|
|
|Complete
|complete
|
|
|FQR
|FQR
Line 34: Line 34:
|
|
|
|
|PENDING
|complete
|
|
|FQR
|FQR
Line 44: Line 44:
|
|
|
|
|PENDING
|complete
|
|
|FQR
|FQR
Line 54: Line 54:
|
|
|
|
|PENDING
|complete
|
|
|FQR
|FQR
|
|8/4/2020 before submission
|
|
|-
|-
|    Essential  Thrombocythaemia (ET)||Disease
|    Essential  Thrombocythaemia (ET)||Disease
|Rebecca Smith (trainee) + faculty TBD
|Rebecca Smith (trainee) + Fabiola Quintero-Rivera
|
|
|
|
|PENDING
|complete/pending faculty review
|
|
|FQR
|FQR
Line 71: Line 71:
|-
|-
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|Mark Evans (trainee), Fabiola Quintero-Rivera
|(trainee), Daynna J.Wolff
|
|
|
|
|PENDING
|pending faculty review
|
|
|FQR
|FQR
Line 81: Line 81:
|-
|-
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|Mark Evans (trainee)+ Fabiola Quintero-Rivera
|Thomas Lee
|
|8/17/2020
|
|9/7/2020
|PENDING
|complete
|
|
|FQR
|FQR
Line 90: Line 90:
|
|
|-
|-
|'''''Mastocytosis'''''||'''''Overview'''''||
|'''''Mastocytosis'''''||'''''Overview'''''||'''Shashi Shetty, Ph.D.'''
|
|
|
|
|
|complete
| ||FQR
| ||FQR
|
|
Line 99: Line 99:
|-
|-
|    Cutaneous  Mastocytosis||Disease
|    Cutaneous  Mastocytosis||Disease
|Thuy Phung
|Thuy Phung/Shuo-Shawn Liu
|
|
|
|
|PENDING
|complete/pending adding content online as of 2/4/21
|
|
|FQR
|FQR
Line 112: Line 112:
|
|
|
|
|PENDING
|complete
|
|
|FQR
|FQR
Line 119: Line 119:
|-
|-
|    Mast Cell Sarcoma||Disease
|    Mast Cell Sarcoma||Disease
|Thuy Phung
|Thuy Phung +Jordan Lowery
|
|
|
|
|PENDING
|complete
|
|
|FQR
|FQR
Line 131: Line 131:
|
|
|
|
|PENDING
|complete
|
|
|FQR
|FQR
Line 224: Line 224:
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|
|
|
|9/1/20
|PENDING
|PENDING
|
|
Line 234: Line 234:
|
|
|
|
|PENDING
|complete
|
|
|FQR
|FQR
Line 243: Line 243:
|
|
|
|
|PENDING
|complete
|
|
|FQR
|FQR
Line 251: Line 251:
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
|
|
|
|9/1/20
|
|pending
|
|
|FQR
|FQR
Line 260: Line 260:
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
|
|
|
|9/1/20
|PENDING
|PENDING
|
|
Line 285: Line 285:
|
|
|-
|-
|    Myelodysplastic syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|
|
|9/1/20
|PENDING
|PENDING
|
|
Line 296: Line 296:
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|
|
|9/1/20
|PENDING
|PENDING
|
|
Line 315: Line 315:
|
|
|
|
|PENDING
|complete
|
|
|FQR
|FQR
Line 323: Line 323:
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|
|
|9/1/20
|PENDING
|PENDING
|
|
Line 344: Line 344:
|
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|
|04/26/2021 -MS (re-review)
|
|
|-
|-
Line 352: Line 352:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|
|03/01/2021-MS (re-review)
|
|
|-
|-
Line 360: Line 360:
|PENDING
|PENDING
| ||JH / MS
| ||JH / MS
|
|04/26/2021 -MS (re-review)
|
|
|-
|-
Line 366: Line 366:
|
|
|
|
|PENDING
|Complete
| ||JH / MS
| ||JH / MS
|
|03/01/2021-MS
|
|
|-
|-
Line 374: Line 374:
|
|
|
|
|PENDING
|Complete
| ||JH / MS
|02/03/2021||JH / MS
|
|
|
|
Line 382: Line 382:
|
|
|
|
|PENDING
|Complete
| ||JH / MS
| ||JH / MS
|
|03/02/2021-MS
|
|
|-
|-
Line 392: Line 392:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|
|03/02/2021-MS (re-review)
|
|
|-
|-
Line 400: Line 400:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|
|04/26/2021 -MS (re-review)
|
|
|-
|-
Line 409: Line 409:
|
|
|JH / MS
|JH / MS
|
|03/01/2021-MS (re-review)
|
|
|-
|-
Line 417: Line 417:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|
|04/26/2021-MS (re-review)
|
|
|-
|-
Line 425: Line 425:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|
|03/01/2021-MS (re-review)
|
|
|-
|-
Line 433: Line 433:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|
|03/01/2021-MS (re-review)
|
|
|-
|-
Line 441: Line 441:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|
|03/01/2021-MS (re-review)
|
|
|-
|-
Line 449: Line 449:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|
|02/24/2021-MS (re-review)
|
|
|-
|-
Line 674: Line 674:
| ||JH / MS
| ||JH / MS
|
|
|Check reference format
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
Line 684: Line 684:
|
|
|-
|-
|    ??Mixed-Phenotype Acute Leukaemia, Not  Otherwise Specified (NOS), Rare Types||Disease||
|    Mixed-Phenotype Acute Leukemia, Not  Otherwise Specified (NOS), Rare Types||Disease||Daynna Wolff+ Elicia Goodale (resident)
|
|
|
|
|??
|PENDING
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
|    ??Acute Leukaemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease||
|    Acute Leukemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease||Daynna Wolff+Madison Hannay or Elicia Goodale (residents)
|
|
|
|
|??
|PENDING
| ||JH / MS
| ||JH / MS
|
|
Line 757: Line 757:
|
|
|-
|-
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain + Yassmine Akkari
|
|
|
|
|
|PENDING
| ||YA
| ||YA
|
|
Line 774: Line 774:
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
|
|
|
|
|
|PENDING
| ||YA
| ||YA
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
|
|
|
|
|
|PENDING
| ||YA
| ||YA
|
|
Line 801: Line 801:
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
|
|
|
|
|
|PENDING
| ||YA
| ||YA
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
|
|
|
|
|
|PENDING
| ||YA
| ||YA
|
|
Line 826: Line 826:
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||Holli Drendel
|
|
|
|
|
|PENDING
| ||YA
| ||YA
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||Holli Drendel
|
|
|
|
|
|PENDING
| ||YA
| ||YA
|
|
|
|
|-
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
|Disease
|Diana Rush
|
|
|
|
|PENDING
|
|
| ||YA
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
|Disease
|Celeste Eno
|
|
|
|
|PENDING
|
|
| ||YA
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|Disease
|Marilena Melas
|
|
|
|
|PENDING
|
|
| ||YA
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
|Disease
|Disease
|Helene Bruyere
|Chenkai Ma
|
|
|
|
Line 877: Line 886:
|NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
| || ||
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
|Disease
|Celeste Eno
|
|
|
|
|PENDING
|
|
| ||
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
|Disease
|Alaa Koleilat
|
|
|
|
|PENDING
|
|
| ||Snehal Patel (SP)
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
|
|
|
|
|PENDING
|PENDING
|
| ||YA
|SP
|
|
|
|
|-
|-
|       Monoclonal B-cell  Lymphocytosis||Disease||Honey Reddi
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
|
|
|
|
|PENDING
|PENDING
|
| ||YA
|SP
|
|
|
|
|-
|-
|B-cell Prolymphocytic Leukemia||Disease||Honey Reddi
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
|
|
|
|
|PENDING
|PENDING
| ||YA
|
|
|SP
|
|
|-
| || ||
|
|
|-
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|
|
|
|
|Complete
| ||
|
|
|SP
|
|
|Malini to review
|-
|-
|Hairy Cell Leukemia||Disease||Snehal Patel
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
|Complete
| ||Snehal Patel (SP)
|
|
|SP
|
|
|Malini to review
|-
|-
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||
|
|
|
|
|
|Complete
|
|
|SP
|SP
|
|
|Malini to review
|
|-
|-
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|       Monoclonal B-cell Lymphocytosis||Disease||
|
|
|
|
|
|Complete
|
|
|SP
|SP
|
|
|Malini to review
|
|-
|-
|    Hairy Cell Leukemia Variant||Disease||Snehal Patel
|B-cell Prolymphocytic Leukemia||Disease||
|
|
|
|
|
|Complete
|
|
|SP
|SP
|
|
|Malini to review
|
|-
|-
|Lymphoplasmacytic Lymphoma||Disease||Honey Reddi
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|
|
|
|
|PENDING
|Complete
|
|
|SP
|SP
Line 974: Line 984:
|
|
|-
|-
|   Waldenstrom  Macroglobulinemia||Disease||Honey Reddi
|Hairy Cell Leukemia||Disease||Snehal Patel
|
|
|
|
|PENDING
|Complete
|
|
|SP
|SP
Line 983: Line 993:
|
|
|-
|-
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|
|
|
|
|Complete
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|
|
|
|
|Complete
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|    Mu Heavy Chain Disease||Disease||
|    Hairy Cell Leukemia Variant||Disease||Snehal Patel
|
|
|
|
|Complete
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|   Gamma Heavy Chain  Disease||Disease||
|Lymphoplasmacytic Lymphoma||Disease||
|
|
|
|
|
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|    Alpha Heavy Chain Disease||Disease||
|   Waldenstrom Macroglobulinemia||Disease||
|
|
|
|
|
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|    Mu Heavy Chain  Disease||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|    Plasma Cell Myeloma Variants||Disease||Zhenya Tang
|   Gamma Heavy Chain Disease||Disease||Manisha Sutariya
|
|
|
|
|PENDING
|Complete
|
|5/26/2021||SP
|SP
|
|
|
|
|-
|-
|    Plasmacytoma||Disease||Zhenya Tang
|    Alpha Heavy Chain  Disease||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|           Primary Amyloidosis||Disease||
|   Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|           Light Chain  and Heavy Chain Deposition Disease||Disease||
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|         POEMS Syndrome||Disease||
|    Plasmacytoma||Disease||Zhenya Tang
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|         TEMPI Syndrome||Disease||
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|
|
|
|
Line 1,116: Line 1,131:
|
|
|-
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee
|           Primary Amyloidosis||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|Nodal Marginal Zone Lymphoma||Disease||
|           Light Chain  and Heavy Chain Deposition Disease||Disease||
|
|
|
|
Line 1,133: Line 1,147:
|
|
|-
|-
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|Follicular Lymphoma||Disease||Ruthann Pfau
|         POEMS Syndrome||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
|         TEMPI Syndrome||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|    In Situ Follicular Neoplasia||Disease||Ruthann Pfau
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Whayoung Lee, trainee)/Fabiola Quintero-Rivera
|
|3/9/21
|
|
|PENDING
|PENDING
Line 1,169: Line 1,180:
|
|
|-
|-
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
|
|
|
|
|PENDING
|Complete
|
|5/28/2021||SP
|SP
|
|
|
|
|-
|-
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|
|
|PENDING
|Complete
|
|11/11/2020
|SP
|SP
|
|
|
|
|-
|-
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||
|Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|Primary Cutaneous Follicle Centre Lymphoma||Disease||
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
|
|
|
|8/15/20
|PENDING
|PENDING
|
|
Line 1,212: Line 1,224:
|
|
|-
|-
|    Leukemic Non-Nodal Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|    Duodenal-Type Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|
|8/31/20
|PENDING
|PENDING  
|
|
|SP
|SP
Line 1,221: Line 1,233:
|
|
|-
|-
|    In Situ Mantle Cell  Neoplasia||Disease||Mahsa Khanlari
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|8/15/20
|PENDING
|
|
|Complete
|8/16/2020
|SP
|SP
|
|
|
|
|-
|-
| || ||
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
|
|
|
|
|9/30/20
| ||
|Complete
|5/26/2021||SP
|
|
|
|
|-
|-
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
|
|
|
|
|PENDING
|PENDING
|
| ||SP
|Greg Corboy (GC)
|
|
|
|
|-
|-
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|
|
|8/15/20
|PENDING
|
|
|SP
|
|
| ||GC
|
|
|-
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||
|
|
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|
|
|
|
|
|
| ||GC
|SP
|
|
|
|
|-
|-
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|    In Situ Mantle Cell  Neoplasia||Disease||
|
|
|
|
|
|
|
| ||GC
|SP
|
|
|
|
|-
|-
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease||
| || ||
|
|
|
|
|
|
| ||GC
| ||
|
|
|
|
|-
|-
|EBV-Positive Mucocutaneous Ulcer||Disease||
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
|
|
|
|
|PENDING
|
|
| ||GC
|Greg Corboy (GC)
|
|
|
|
|-
|-
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|
|
|
|
Line 1,295: Line 1,310:
|
|
|-
|-
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|
|
|
|
Line 1,303: Line 1,318:
|
|
|-
|-
|Lymphomatoid Granulomatosis||Disease||
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|
|
|
|
Line 1,311: Line 1,326:
|
|
|-
|-
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease||
|
|
|
|
Line 1,319: Line 1,334:
|
|
|-
|-
|Intravascular Large B-cell Lymphoma||Disease||
|EBV-Positive Mucocutaneous Ulcer||Disease||
|
|
|
|
Line 1,327: Line 1,342:
|
|
|-
|-
|ALK-Positive Large B-cell Lymphoma||Disease||
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
|
|
|
|
Line 1,335: Line 1,350:
|
|
|-
|-
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
|
|
|
|
|
|Complete
| ||GC
| ||GC
|
|
|
|
|-
|-
|Primary Effusion Lymphoma||Disease||
|Lymphomatoid Granulomatosis||Disease||
|
|
|
|
Line 1,351: Line 1,366:
|
|
|-
|-
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|
|
|
|
Line 1,359: Line 1,374:
|
|
|-
|-
|   Multicentric Castleman  Disease||Disease||
|Intravascular Large B-cell Lymphoma||Disease||
|
|
|
|
Line 1,367: Line 1,382:
|
|
|-
|-
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|ALK-Positive Large B-cell Lymphoma||Disease||
|
|
|
|
Line 1,375: Line 1,390:
|
|
|-
|-
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|
|
|
|Complete
| ||GC
| ||GC
|
|
|
|
|-
|-
|Burkitt Lymphoma||Disease||
|Primary Effusion Lymphoma||Disease||
|
|
|
|
Line 1,391: Line 1,406:
|
|
|-
|-
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
Line 1,399: Line 1,414:
|
|
|-
|-
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|   Multicentric Castleman  Disease||Disease||
|
|
|
|
Line 1,407: Line 1,422:
|
|
|-
|-
|    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
Line 1,415: Line 1,430:
|
|
|-
|-
|    High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|   HHV8-Positive Germinotropic Lymphoproliferative Disorder||Disease||
|
|
|
|
Line 1,423: Line 1,438:
|
|
|-
|-
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
|
|3/11/21
|
|
|
|PENDING
| ||GC
| ||GC
|
|
|
|
|-
|-
| || ||
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||Snehal Patel (SP)
| ||GC
|
|
|
|
|-
|-
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
|
|
|
|
|
|PENDING
| ||GC
| ||SP
|
|
|
|
|-
|-
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|    High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
|PENDING
| ||GC
| ||SP
|
|
|
|
|-
|-
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
|PENDING
| ||GC
| ||SP
|
|
|
|
|-
|-
|Aggressive NK-cell Leukemia||Disease||
| || ||
|
|
|
|
|
|
| ||SP
| ||
|
|
|
|
|-
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||SP
| ||Snehal Patel (SP)
|
|
|
|
|-
|-
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|    Severe Mosquito Bite  Allergy||Disease||
|Aggressive NK-cell Leukemia||Disease||
|
|
|
|
Line 1,519: Line 1,534:
|
|
|-
|-
|Adult T-cell Leukemia/Lymphoma||Disease||
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|
|
|
|
Line 1,527: Line 1,542:
|
|
|-
|-
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|      Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|     Monomorphic Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|    Severe Mosquito Bite Allergy||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|     Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|Adult T-cell Leukemia/Lymphoma||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|    Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|PENDING
| ||SP
|
|SP
|
|
|
|
|-
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|
|Complete
| ||SP
|1/21/2021
|SP
|
|
|
|
|-
|-
|Mycosis Fungoides||Disease||
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|Sézary Syndrome||Disease||
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders'''''||'''''Overview'''''||
|    Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|    Lymphomatoid  Papulosis||Disease||
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|
|
|
|
|
|Complete
| ||SP
|1/21/2021
|SP
|
|
|
|
|-
|-
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease||
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|
|
|
|
Line 1,636: Line 1,652:
|
|
|-
|-
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee)
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
|
|
|
|
Line 1,660: Line 1,676:
|
|
|-
|-
|     Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease||
|    Lymphomatoid Papulosis||Disease||
|
|
|
|
Line 1,668: Line 1,684:
|
|
|-
|-
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease||
|
|
|
|
Line 1,676: Line 1,692:
|
|
|-
|-
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
|
|
|
|
Line 1,684: Line 1,700:
|
|
|-
|-
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
|
|
|
|
Line 1,692: Line 1,708:
|
|
|-
|-
|     Angioimmunoblastic T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|    Follicular T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|     Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype||Disease||
|     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
|
|
|
|
Line 1,718: Line 1,732:
|
|
|-
|-
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|
|
Line 1,745: Line 1,757:
|
|
|-
|-
| || ||
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|
|
|PENDING
|
|
| ||
|SP
|
|
|
|
|-
|-
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|
|
|
|
|
|PENDING
| ||Associate Editor??
| ||SP
|
|
|
|
|-
|-
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
| ||
|SP
|
|
|
|
|-
|-
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
| ||
|SP
|
|
|
|
|-
|-
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
| ||
|SP
|
|
|
|
|-
|-
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease||
| || ||
|
|
|
|
Line 1,793: Line 1,809:
|
|
|-
|-
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease||
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||
| ||Greg Corboy (GC)
|
|
|
|
|-
|-
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|Lymphomas Associated with HIV Infection||Disease||
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|    Non-Destructive Post-Transplant Lymphoproliferative Disorders||Disease||
|    Mixed Cellularity Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|    Polymorphic Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
|    Lymphocyte-Depleted Classic Hodgkin Lymphoma||Disease||
 
Fabiola Quintero-Rivera
|
|
|
|PENDING
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|          Monomorphic  B-cell PTLD||Disease||
|Lymphomas Associated with HIV Infection||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|          Monomorphic  T/NK-cell PTLD||Disease||
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|    Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|    Non-Destructive Post-Transplant Lymphoproliferative Disorders||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders||Disease||
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
 
Fabiola Quintero-Rivera
|
|
|
|
|PENDING
|
|
| ||
|GC
|
|
|
|
|-
|-
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|Histiocytic Sarcoma||Disease||
|          Monomorphic  B-cell PTLD||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|          Monomorphic  T/NK-cell PTLD||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|   Langerhans Cell Histiocytosis||Disease||
|    Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|   Langerhans Cell Sarcoma||Disease||
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|Indeterminate Dendritic Cell Tumour||Disease||
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|Interdigitating Dendritic Cell Sarcoma||Disease||
|Histiocytic Sarcoma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|Follicular Dendritic Cell Sarcoma||Disease||
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|    Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|   Langerhans Cell Histiocytosis||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|   Langerhans Cell Sarcoma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|Indeterminate Dendritic Cell Tumour||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|Erdheim-Chester Disease||Disease||
|Interdigitating Dendritic Cell Sarcoma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|Follicular Dendritic Cell Sarcoma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|-
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|
|
|
| ||GC
|
|
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|
|
|
| ||GC
|
|
|-
|Erdheim-Chester Disease||Disease||
|
|
|
| ||GC
|
|
|-
| || ||
|
|
|
| ||
|
|
|
|
Line 2,157: Line 2,213:
!'''Date Completed by Author'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Associate Editor'''
!Author Content
(Pending or Complete)
!'''Date of Last Editor Review'''
!'''Date of Last Editor Review'''
!'''Notes'''
!'''Notes'''
Line 2,169: Line 2,223:
|8/10/18
|8/10/18
|
|
|Complete (8/10/18)
|
|
|
|
Line 2,180: Line 2,233:
|4/16/19
|4/16/19
|
|
|Complete (4/16/19)
|
|
|
|
Line 2,191: Line 2,243:
|6/9/19
|6/9/19
|
|
|Complete (6/9/19)
|
|
|
|
Line 2,202: Line 2,253:
|5/23/19
|5/23/19
|
|
|Complete (5/23/19)
|
|
|
|
Line 2,213: Line 2,263:
|8/6/18
|8/6/18
|
|
|Complete (8/6/18)
|
|
|
|
Line 2,224: Line 2,273:
|
|
|
|
|Complete (
|
|
|
|
Line 2,235: Line 2,283:
|
|
|
|
|Complete (
|
|
|
|
Line 2,246: Line 2,293:
|
|
|
|
|Complete (
|
|
|
|
Line 2,257: Line 2,303:
|
|
|
|
|Complete (
|
|
|
|
Line 2,268: Line 2,313:
|
|
|
|
|Complete (
|
|
|
|
Line 2,279: Line 2,323:
|
|
|
|
|Complete (
|
|
|
|
Line 2,290: Line 2,333:
|
|
|
|
|Complete (
|
|
|
|
Line 2,301: Line 2,343:
|12/5/18
|12/5/18
|
|
|Complete (12/5/18)
|
|
|
|
Line 2,312: Line 2,353:
|8/3/18
|8/3/18
|
|
|Complete (8/3/18)
|
|
|
|
Line 2,323: Line 2,363:
|6/9/19
|6/9/19
|
|
|Complete (6/9/19)
|
|
|
|
Line 2,334: Line 2,373:
|10/1/18
|10/1/18
|
|
|Complete (10/1/18)
|
|
|
|
Line 2,345: Line 2,383:
|8/2/18
|8/2/18
|
|
|Complete (8/2/18)
|
|
|
|
Line 2,356: Line 2,393:
|
|
|
|
|Complete (
|
|
|
|
Line 2,367: Line 2,403:
|
|
|
|
|Pending
|
|
|
|
|-
|-
|MLTT3
|MLTT3
|
|
|
|
|
Line 2,389: Line 2,423:
|
|
|
|
|Pending
|
|
|
|
Line 2,400: Line 2,433:
|
|
|
|
|Pending
|
|
|
|
|-
|-
|KMT2A
|KMT2A
|
|
|
|
|
Line 2,416: Line 2,447:
|-
|-
|DEK
|DEK
|Wahab A. Khan
|
|
|
|
|
|Pending
|
|
|
|
|
|
Line 2,427: Line 2,457:
|-
|-
|NUP214
|NUP214
|Wahab A. Khan
|
|
|
|
|
|Pending
|
|
|
|
|
|
Line 2,438: Line 2,467:
|-
|-
|RBM15
|RBM15
|
|
|
|
|
Line 2,449: Line 2,477:
|-
|-
|MKL1
|MKL1
|
|
|
|
|
Line 2,460: Line 2,487:
|-
|-
|DDX41
|DDX41
|Ying Zou
|8/7/20
|
|
|
|Pending
|
|
|
|
|
|
|
Line 2,471: Line 2,497:
|-
|-
|ANKRD26
|ANKRD26
|
|
|
|
|
Line 2,482: Line 2,507:
|-
|-
|CUX1
|CUX1
|
|
|
|
|
Line 2,493: Line 2,517:
|-
|-
|TET2
|TET2
|
|
|
|
|
Line 2,504: Line 2,527:
|-
|-
|EZH2
|EZH2
|
|
|
|
|
Line 2,515: Line 2,537:
|-
|-
|FOXP1
|FOXP1
|
|
|
|
|
Line 2,526: Line 2,547:
|-
|-
|MYC
|MYC
|
|
|
|
|
Line 2,537: Line 2,557:
|-
|-
|JAK2
|JAK2
|
|
|
|
|
Line 2,548: Line 2,567:
|-
|-
|WT1
|WT1
|DONE
|
|
|
|
|
|DONE
|
|
|
|
|
|
Line 2,559: Line 2,577:
|-
|-
|CBL
|CBL
|
|
|
|
|
Line 2,570: Line 2,587:
|-
|-
|NF1
|NF1
|
|
|
|
|
Line 2,581: Line 2,597:
|-
|-
|SUZ12
|SUZ12
|
|
|
|
|
Line 2,592: Line 2,607:
|-
|-
|ERG
|ERG
|
|
|
|
|
Line 2,603: Line 2,617:
|-
|-
|EST2
|EST2
|
|
|
|
|
Line 2,614: Line 2,627:
|-
|-
|RPS14
|RPS14
|
|
|
|
|
Line 2,625: Line 2,637:
|-
|-
|RB1
|RB1
|
|
|
|
|
Line 2,636: Line 2,647:
|-
|-
|MPL
|MPL
|
|
|
|
|
Line 2,647: Line 2,657:
|-
|-
|CHGA
|CHGA
|
|
|
|
|
Line 2,658: Line 2,667:
|-
|-
|CDH1
|CDH1
|
|
|
|
|
Line 2,669: Line 2,677:
|-
|-
|SRSF2
|SRSF2
|
|
|
|
|
Line 2,680: Line 2,687:
|-
|-
|DNMT1
|DNMT1
|
|
|
|
|
Line 2,691: Line 2,697:
|-
|-
|PRDX2
|PRDX2
|
|
|
|
|
Line 2,702: Line 2,707:
|-
|-
|ASXL1
|ASXL1
|DONE
|
|
|
|
|
|DONE
|
|
|
|
|
|
Line 2,713: Line 2,717:
|-
|-
|MN1
|MN1
|
|
|
|
|
Line 2,724: Line 2,727:
|-
|-
|SF3A1
|SF3A1
|
|
|
|
|
Line 2,735: Line 2,737:
|-
|-
|EP300
|EP300
|
|
|
|
|
Line 2,746: Line 2,747:
|-
|-
|JARID2
|JARID2
|
|
|
|
|
Line 2,756: Line 2,756:
|
|
|-
|-
|
|BRCA1
|
|
|
|
|
Line 2,767: Line 2,766:
|
|
|-
|-
|
|BRCA2
|
|
|
|
|
Line 2,778: Line 2,776:
|
|
|-
|-
|
|
|
|
|
Line 2,789: Line 2,786:
|
|
|-
|-
|
|
|
|
|
Retrieved from "https://content.ccga.io/index.php/Volunteer_Assignments_and_Opportunities"